Abstract: The invention provides an adjustable insulator for use with a can or bottle of drink, including a substantially planar body having a first end and a second end. The adjustable insulator includes adjustment means associated with the substantially planar body, including a first adjustment means part, associated with the first end of the substantially planar body, and a second adjustment means part, associated with the second end of the substantially planar body. The first and second parts together can adjustably connect so the first adjustment means part and second adjustment means part reciprocally connect in an adjustable manner for use about the can or bottle. The invention also relates to variants thereon and a method of use.

Abstract: A method for facilitating the selling of a beauty care product comprising the step of portraying a first image or image region to communicate skin appearance before using the beauty care product, and portraying a second image or image region to communicate skin appearance after using the beauty care product. The second image or image region appears to have a relatively higher resolution or clarity than the first image or image region.

Abstract: A beauty care product selling aid including a tangible medium of expression, and an image fixed in the tangible medium of expression. The image includes a non-skin illustration having a first geometrical figure and a second geometrical figure, wherein the first geometrical figure comprises pixels that are individually discernable with the naked eye and the second geometrical figure is or appears to be substantially devoid of the pixels that are individually discernable with the naked eye. The visual contrast between the first geometrical figure and the second geometrical figure provides imagery to communicate a visual transformation in skin appearance that may occur by using the beauty care product.

Abstract: The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.